Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells
Author:
Affiliation:
1. Department of Dermatology; University of Florence; Florence Italy
2. Division of Pathological Anatomy; Department of Surgery and Translational Medicine; University of Florence; Florence Italy
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ced.12469/fullpdf
Reference10 articles.
1. Subungual acrolentiginous amelanotic melanoma treated with amputation of the distal and middle phalanges;Guarneri;Wien Med Wochenschr,2013
2. Topical 5% imiquimod in the treatment of lentigo maligna;Wong;J Cutan Med Surg,2012
3. A randomized trial of the off-label use of imiquimod, 5%, cream with vs. without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions;Hyde;Arch Dermatol,2012
4. Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis;Turza;J Cutan Pathol,2010
5. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies;Geisse;J Am Acad Dermatol,2004
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Subclinical persistence of residual acral melanoma in situ after treatment with topical imiquimod and retinoid creams;JAAD Case Reports;2024-03
2. Recent advancements in the diagnosis and treatment of acral melanoma;Journal of Zhejiang University-SCIENCE B;2024-02
3. Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature;Dermatology and Therapy;2023-08-24
4. RECURRENT LENTIGO MALIGNA: CONSERVATIVE CONTINUOUS TREATMENT WITH IMIQUIMOD OR REPEATED SURGERY? A LONG-TERM FOLLOW-UP DERMOSCOPIC CASE STUDY;Experimental Oncology;2023-06-26
5. Acral Melanoma;Melanoma in Clinical Practice;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3